Search

everythinglearnresearchcommunity

for

Search:↓

Being allergic to linalool, a common fragrance ingredient, might contribute to developing frontal fibrosing alopecia.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

ILC1-like cells may contribute to hair loss in alopecia areata.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Dandruff is linked to changes in the immune system of hair follicles and skin.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Mitochondrial stress can lead to atopic dermatitis.

ILC1-like cells can cause alopecia areata by themselves.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Different types of skin cells and immune cells play a role in healing UV-damaged skin, with chronic UV exposure causing lasting damage to certain skin cells.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

The humanized AA mouse model is better for testing new alopecia areata treatments.

Lichen Planopilaris causes irreversible hair loss due to immune attacks on hair stem cells, but modulating PPAR-γ might help treat it.

Skin bacteria can help wound healing by activating certain immune cells.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Certain microRNAs may protect against hair loss in alopecia areata and could be potential treatment targets.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.